When did Ironwood Pharmaceuticals report Q4 2024 earnings?

Ironwood Pharmaceuticals (IRWD) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Ironwood Pharmaceuticals's Q4 2024 revenue and EPS?

Ironwood Pharmaceuticals reported revenue of $90.5M and eps of $0.02 for Q4 2024.

Did Ironwood Pharmaceuticals beat estimates in Q4 2024?

Revenue beat the consensus estimate of $67.0M by $23.5M. EPS missed the consensus estimate of $0.10 by $0.08.

Where can I find Ironwood Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-004072) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ironwood Pharmaceuticals IRWD Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$90.5MBeat by $23.5M

EPS$0.02Miss by $0.08

Revenue estimate$67.0M

EPS estimate$0.10

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$114.8M

EPS estimate$0.32

Financials

Q4 2024

Income statement

See full

Revenue$90.5M-23.0%

Operating income$31.5M—

Net income$2.3M+308%

EPS (diluted)$0.01+200%

Balance sheet

See full

Cash & equivalents$88.6M-3.9%

Total debt$15.5M-92.9%

Total equity-$301.3M+13.0%

Total assets$350.9M-25.5%

Cash flow

See full

Operating cash flow$15.2M-57.5%

CapEx--100%

Free cash flow$15.2M-57.3%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$708.93M-60.3%

Enterprise value$635.86M-66.7%

P/E805.6×—

P/S2×-2.0×

Profitability

See full

Operating margin26.5%+14.0pp

Net margin0.3%+0.1pp

FCF margin29.4%-11.9pp

Returns & leverage

See full

Current ratio4.7×+3.8×

Segments

By product

See full

Collaborative Arrangement Development And Commercialization Agreements$298.0K-70.2%

Versus estimates

Revenue

Q1 2026$106.5MBeat by $14.4M Q4 2025$47.7MMiss by $3.2M Q3 2025$122.1MBeat by $71.1M Q2 2025$85.2MBeat by $7.4M Q1 2025$41.1MMiss by $29.9M

Q4 2024$90.5MBeat by $23.5M

Diluted EPS

Q1 2026$0.24Beat by $0.17 Q4 2025-$0.01Miss by $0.03 Q3 2025$0.24Beat by $0.15 Q2 2025$0.14Beat by $0.16 Q1 2025-$0.14Miss by $0.09

Q4 2024$0.02Miss by $0.08

Ask the moment Ironwood Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Ironwood Pharmaceuticals report Q4 2024 earnings?: Ironwood Pharmaceuticals (IRWD) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Ironwood Pharmaceuticals's Q4 2024 revenue and EPS?: Ironwood Pharmaceuticals reported revenue of $90.5M and eps of $0.02 for Q4 2024.
Did Ironwood Pharmaceuticals beat estimates in Q4 2024?: Revenue beat the consensus estimate of $67.0M by $23.5M. EPS missed the consensus estimate of $0.10 by $0.08.
Where can I find Ironwood Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-004072) directly on SEC EDGAR. The filing index links above go to sec.gov.